Avricore Health (AVCRF) Other Non-Current Liabilities (2017 - 2021)
Avricore Health (AVCRF) posted quarterly Other Non-Current Liabilities of $16202.9 for Q4 2019, down 79.42% quarter-over-quarter from $78714.2 in Q4 2017.
Avricore Health (AVCRF) Other Non-Current Liabilities (2017 - 2021) Analysis & Trends
Avricore Health (AVCRF) has reported Other Non-Current Liabilities for 2 consecutive years, with $16202.9 the latest figure, recorded in Q4 2019.
- In Q4 2019, Other Non-Current Liabilities changed N/A year-over-year to $16202.9; the TTM figure through Dec 2019 stood at $16202.9 (changed N/A YoY), while the FY2019 annual figure was $16121.2, changed N/A from the prior year.
- Other Non-Current Liabilities slipped to $16202.9 in Q4 2019 per AVCRF's latest filing, from $78714.2 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $78714.2 in Q4 2017 and bottomed at $16202.9 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6.20 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 12.91 Mn |
| Sep 30, 2021 | 12.93 Mn |
| Jun 30, 2021 | 13.24 Mn |
| Dec 31, 2020 | 4.97 Mn |
| Dec 31, 2019 | 16,202.89 |
| Dec 31, 2017 | 78,714.22 |